MX2009010439A - Variantes geneticas de chr2 y chr16 como marcadores para el uso en valoracion, diagnosis, prognosis y tratamiento de riesgo de cancer de mama. - Google Patents

Variantes geneticas de chr2 y chr16 como marcadores para el uso en valoracion, diagnosis, prognosis y tratamiento de riesgo de cancer de mama.

Info

Publication number
MX2009010439A
MX2009010439A MX2009010439A MX2009010439A MX2009010439A MX 2009010439 A MX2009010439 A MX 2009010439A MX 2009010439 A MX2009010439 A MX 2009010439A MX 2009010439 A MX2009010439 A MX 2009010439A MX 2009010439 A MX2009010439 A MX 2009010439A
Authority
MX
Mexico
Prior art keywords
breast cancer
diagnosis
risk assessment
chr16
chr2
Prior art date
Application number
MX2009010439A
Other languages
English (en)
Spanish (es)
Inventor
Patrick Sulem
Andrei Manolescu
Simon Stacey
Original Assignee
Decode Genetics Ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Decode Genetics Ehf filed Critical Decode Genetics Ehf
Publication of MX2009010439A publication Critical patent/MX2009010439A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
MX2009010439A 2007-03-26 2008-03-26 Variantes geneticas de chr2 y chr16 como marcadores para el uso en valoracion, diagnosis, prognosis y tratamiento de riesgo de cancer de mama. MX2009010439A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS8625 2007-03-26
IS8648 2007-05-25
PCT/IS2008/000009 WO2008117314A2 (en) 2007-03-26 2008-03-26 Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment

Publications (1)

Publication Number Publication Date
MX2009010439A true MX2009010439A (es) 2009-10-20

Family

ID=39563444

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009010439A MX2009010439A (es) 2007-03-26 2008-03-26 Variantes geneticas de chr2 y chr16 como marcadores para el uso en valoracion, diagnosis, prognosis y tratamiento de riesgo de cancer de mama.

Country Status (13)

Country Link
US (1) US20110117545A1 (enExample)
EP (3) EP2540840A3 (enExample)
JP (1) JP5676245B2 (enExample)
KR (1) KR20090127939A (enExample)
CN (1) CN101874120B (enExample)
AU (1) AU2008231425B2 (enExample)
CA (1) CA2681928A1 (enExample)
EA (1) EA019953B1 (enExample)
IL (1) IL201217A (enExample)
MX (1) MX2009010439A (enExample)
NZ (1) NZ580490A (enExample)
WO (1) WO2008117314A2 (enExample)
ZA (1) ZA200907471B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9827314B2 (en) 2003-12-08 2017-11-28 Mars, Incorporated Edible compositions which are adapted for use by a companion animal
EP2463388B1 (en) 2005-11-29 2017-11-22 Cambridge Enterprise Limited Markers for breast cancer
CN102144036B (zh) 2008-07-07 2014-07-16 解码遗传学私营有限责任公司 用于乳腺癌风险评估的遗传变型
JP2012504410A (ja) * 2008-10-03 2012-02-23 マース インコーポレーテッド イヌにおける肝臓の銅蓄積についての遺伝子検査およびペット用低銅食餌
EP2438193B1 (en) * 2009-06-01 2015-07-22 Genetic Technologies Limited Methods for breast cancer risk assessment
US8356023B2 (en) * 2009-07-28 2013-01-15 Ancestry.Com Operations Inc. Collaborative systems and methods for constructing representations of data
US20140329719A1 (en) * 2011-06-16 2014-11-06 Illumina, Inc. Genetic variants for predicting risk of breast cancer
GB201120989D0 (en) 2011-12-06 2012-01-18 Mars Inc Genetic test
KR101390590B1 (ko) * 2012-06-28 2014-04-30 서울대학교산학협력단 췌장암 재발 예후 예측용 마커 및 이의 용도
EP2968371A4 (en) 2013-03-12 2017-04-12 The Board of Trustees of the Leland Stanford Junior University Modulation of cellular dna repair activity to intercept malignancy
EP3201360A4 (en) * 2014-09-30 2018-05-09 Genetic Technologies Limited Methods for assessing risk of developing breast cancer
US20170286594A1 (en) * 2016-03-29 2017-10-05 Regeneron Pharmaceuticals, Inc. Genetic Variant-Phenotype Analysis System And Methods Of Use
CN108588263B (zh) * 2018-06-07 2022-02-01 中国农业科学院烟草研究所 一种用于定位和克隆植物中控制同一性状的双隐性基因的方法
CN108676890B (zh) * 2018-07-12 2022-01-28 吉林大学 一种女性乳腺恶性肿瘤易感性预测试剂盒及系统
US10395772B1 (en) * 2018-10-17 2019-08-27 Tempus Labs Mobile supplementation, extraction, and analysis of health records
AU2019392537A1 (en) 2018-12-03 2021-07-01 Tempus Ai, Inc. Clinical concept identification, extraction, and prediction system and related methods
KR102091790B1 (ko) * 2019-09-02 2020-03-20 주식회사 클리노믹스 피검사자와 생물체 간의 유전자 정보를 이용한 유전적 띠 제공 시스템 및 그 방법
CA3154157A1 (en) 2019-09-13 2021-03-18 23Andme, Inc. Methods and systems for determining and displaying pedigrees
KR20240063050A (ko) * 2022-11-02 2024-05-09 주식회사 디시젠 암 발생 위험도 예측 방법
CN116287258B (zh) * 2023-02-23 2025-08-26 清华大学深圳国际研究生院 一种新型分子标志物在乳腺癌诊断或预后评估中的应用
CN119381001A (zh) * 2025-01-02 2025-01-28 四川大学华西医院 一种乳腺癌复发风险的预测方法、装置、设备及存储介质
CN120805003B (zh) * 2025-09-04 2025-12-02 四川大学华西医院 一种基于多阶段动态优化的时序数据突变检测方法、系统和存储介质

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5424186A (en) * 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5288644A (en) * 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
US5837832A (en) * 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5858659A (en) * 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
AU785425B2 (en) * 2001-03-30 2007-05-17 Genetic Technologies Limited Methods of genomic analysis
US20030170665A1 (en) * 2001-08-04 2003-09-11 Whitehead Institute For Biomedical Research Haplotype map of the human genome and uses therefor
US20040023237A1 (en) * 2001-11-26 2004-02-05 Perelegen Sciences Inc. Methods for genomic analysis
US20040146870A1 (en) * 2003-01-27 2004-07-29 Guochun Liao Systems and methods for predicting specific genetic loci that affect phenotypic traits
PL214402B1 (pl) * 2003-08-11 2013-07-31 Tomasz Byrski Zastosowanie selenu albo jego zwiazku do otrzymywania srodka do obnizania odziedziczonego ryzyka zachorowania na raka piersi lub jajnika
US9157122B2 (en) * 2004-11-11 2015-10-13 Garvan Institute Of Medical Research Method of diagnosing cancer and reagents therefor
KR101138862B1 (ko) * 2005-02-14 2012-05-14 삼성전자주식회사 단일염기 다형을 포함하는 유방암과 관련된 폴리뉴클레오티드, 그를 포함하는 마이크로어레이 및 진단 키트 및 그를이용한 유방암 진단 방법
KR101206028B1 (ko) * 2005-03-05 2012-11-28 삼성전자주식회사 유방암 특이적 다형성 서열을 이용한 유방암의 진단방법,유방암 특이적인 폴리뉴클레오티드 및 상기 폴리뉴클레오티드가 고정되어 있는 마이크로어레이
US7858303B2 (en) * 2005-03-14 2010-12-28 Wisconsin Alumni Research Foundation Method of analyzing breast cancer susceptibility and resistance
WO2006121991A2 (en) * 2005-05-06 2006-11-16 Diadexus, Inc. Compositions and methods for detection, prognosis and treatment of breast cancer

Also Published As

Publication number Publication date
EA019953B1 (ru) 2014-07-30
WO2008117314A3 (en) 2008-12-18
AU2008231425A1 (en) 2008-10-02
JP2010522555A (ja) 2010-07-08
AU2008231425B2 (en) 2014-03-20
NZ580490A (en) 2012-08-31
US20110117545A1 (en) 2011-05-19
IL201217A (en) 2014-03-31
ZA200907471B (en) 2014-03-26
WO2008117314A2 (en) 2008-10-02
EP2540840A2 (en) 2013-01-02
IL201217A0 (en) 2010-05-31
KR20090127939A (ko) 2009-12-14
EA200970891A1 (ru) 2010-04-30
EP2527466A3 (en) 2013-05-15
EP2527466A2 (en) 2012-11-28
CN101874120B (zh) 2015-01-14
EP2540840A3 (en) 2013-05-15
EP2137324A2 (en) 2009-12-30
CN101874120A (zh) 2010-10-27
CA2681928A1 (en) 2008-10-02
JP5676245B2 (ja) 2015-02-25

Similar Documents

Publication Publication Date Title
MX2009010439A (es) Variantes geneticas de chr2 y chr16 como marcadores para el uso en valoracion, diagnosis, prognosis y tratamiento de riesgo de cancer de mama.
MX2009012722A (es) Variantes geneticas sobre chr 5p12 y 10q26 como marcadores para el uso en la evaluacion del riesgo, diagnostico, pronostico y tratamiento del cancer de mama.
WO2010004591A3 (en) Genetic variants for breast cancer risk assessment
MX2009004522A (es) Variantes de suceptibilidad a cancer en chr8q24.21.
MX2010000405A (es) Seleccion de farmacos para terapia de cancer de pulmon usando arreglos a base de anticuerpos.
GB2467467C (en) TAZ/WWTR1 for diagnosis and treatment of cancer
WO2012006589A3 (en) Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
NZ591613A (en) Polymorphic marker rs965513 for risk assessment of thyroid cancer
IL207637A (en) Choosing a Breast Cancer Remedy Using Antibody-Based Arrays
WO2010017515A3 (en) Breast cancer specific markers and methods of use
MX2013002084A (es) Biomarcadores y metodos de tratamiento.
WO2009111643A3 (en) Microrna markers for recurrence of colorectal cancer
ATE527385T1 (de) Mit tumoren assoziierte genetische variationen
MX2009013649A (es) Variantes geneticas en el cromosoma 15q24 como marcadores para usarse en diagnostico, prognosis y tratamiento de sindrome de exfoliacion y glaucoma.
WO2010004590A3 (en) Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment
MX2011012913A (es) Métodos para evaluar el riesgo de cáncer de mama.
WO2011073629A3 (en) Cancer diagnosis and treatment
MX360236B (es) Uso de marcadores en el diagnostico y tratamiento de cancer de prostata.
WO2009015050A3 (en) Gene expression profile for predicting ovarian cancer patient survival
WO2009105457A3 (en) Slit2 cancer markers
WO2006133361A3 (en) Use of gene expression profiling to predict survival in cancer patient
GB2465907A (en) VHZ for diagnosis and treatment of cancer
WO2013081645A3 (en) Erbb3 mutations in cancer
ATE533861T1 (de) Mipol1-etv1-gen-neuanordnungen
MX2007014447A (es) Variantes en cromosoma 8q24.21 que confieren riesgo de cancer.

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration